Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hablando Logopedia provides professional evaluation, diagnosis, prevention and intervention for a wide range of speech-language pathologies. The team consists of licensed speech therapists specializing in both pediatric and adult populations. Services include individualized therapies for communication disorders related to neurodevelopmental conditions (such as autism), acquired neurological diseases (such as Parkinson's or ALS), learning disabilities like dyslexia/dysgraphia, voice problems including those affecting teachers or children with vocal strain/misuse. They also offer school support services for young students and free educational talks for parents/educators. Clinical results are not published but the company emphasizes continuous training and evidence-based practice. No drug development or clinical trial pipeline exists; all services are therapeutic interventions delivered by clinicians.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hablando Logopedia.